MAOA and depressive disorder: The results hoists two compounds, (Z)-9,17-octadecadienal and n-hexadecanoic acid as potential lead molecules for developing novel selective MAO-A inhibitors which can confer herbal remedy in the treatment of psychiatric disorders such as depression, anxiety, and also cognitive impairments in Alzheimer’s and Parkinson’s Diseases.